165 related articles for article (PubMed ID: 15932797)
1. Relationship between prolongation of QTc and prolongation of the peak of T (Tp) to the end of T (Te).
Roche BM; Kijtawornrat A; Hamlin RL; Hamlin DM
J Pharmacol Toxicol Methods; 2005; 52(1):178-81. PubMed ID: 15932797
[TBL] [Abstract][Full Text] [Related]
2. QT prolongation in guinea pigs for preliminary screening of torsadogenicity of drugs and drug-candidates. II.
Testai L; Breschi MC; Martinotti E; Calderone V
J Appl Toxicol; 2007; 27(3):270-5. PubMed ID: 17265420
[TBL] [Abstract][Full Text] [Related]
3. New in vitro model for proarrhythmia safety screening: IKs inhibition potentiates the QTc prolonging effect of IKr inhibitors in isolated guinea pig hearts.
Kui P; Orosz S; Takács H; Sarusi A; Csík N; Rárosi F; Csekő C; Varró A; Papp JG; Forster T; Farkas AS; Farkas A
J Pharmacol Toxicol Methods; 2016; 80():26-34. PubMed ID: 27063345
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity and specificity of isolated perfused guinea pig heart to test for drug-induced lengthening of QTc.
Hamlin RL; Cruze CA; Mittelstadt SW; Kijtawornrat A; Keene BW; Roche BM; Nakayama T; Nakayama H; Hamlin DM; Arnold T
J Pharmacol Toxicol Methods; 2004; 49(1):15-23. PubMed ID: 14670690
[TBL] [Abstract][Full Text] [Related]
5. Validation of a guinea pig Langendorff heart model for assessing potential cardiovascular liability of drug candidates.
Guo L; Dong Z; Guthrie H
J Pharmacol Toxicol Methods; 2009; 60(2):130-51. PubMed ID: 19616638
[TBL] [Abstract][Full Text] [Related]
6. Assessment of drug-induced QT interval prolongation in conscious rabbits.
Kijtawornrat A; Ozkanlar Y; Keene BW; Roche BM; Hamlin DM; Hamlin RL
J Pharmacol Toxicol Methods; 2006; 53(2):168-73. PubMed ID: 16290300
[TBL] [Abstract][Full Text] [Related]
7. Shortening of the electromechanical window in the ketamine/xylazine-anesthetized guinea pig model to assess pro-arrhythmic risk in early drug development.
Morissette P; Regan C; Fitzgerald K; Gerenser P; Travis J; Wang S; Fanelli P; Sannajust F
J Pharmacol Toxicol Methods; 2016; 81():171-82. PubMed ID: 27377419
[TBL] [Abstract][Full Text] [Related]
8. Models of torsades de pointes: effects of FPL64176, DPI201106, dofetilide, and chromanol 293B in isolated rabbit and guinea pig hearts.
Cheng HC; Incardona J
J Pharmacol Toxicol Methods; 2009; 60(2):174-84. PubMed ID: 19524054
[TBL] [Abstract][Full Text] [Related]
9. Choice of cardiac tissue plays an important role in the evaluation of drug-induced prolongation of the QT interval in vitro in rabbit.
Lu HR; Vlaminckx E; Teisman A; Gallacher DJ
J Pharmacol Toxicol Methods; 2005; 52(1):90-105. PubMed ID: 15978848
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced QT prolongation: Concordance of preclinical anesthetized canine model in relation to published clinical observations for ten CiPA drugs.
Koshman YE; Wilsey AS; Bird BM; Endemann AL; Sadilek S; Treadway J; Martin RL; Polakowski JS; Gintant GA; Mittelstadt SW
J Pharmacol Toxicol Methods; 2020; 103():106871. PubMed ID: 32360993
[TBL] [Abstract][Full Text] [Related]
11. Thorough QT/QTc not so thorough: removes torsadogenic predictors from the T-wave, incriminates safe drugs, and misses profibrillatory drugs.
Hondeghem LM
J Cardiovasc Electrophysiol; 2006 Mar; 17(3):337-40. PubMed ID: 16643415
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the effect on dispersion of repolarization of age-adjusted MAC values of sevoflurane in children.
Whyte SD; Sanatani S; Lim J; Booker PD
Anesth Analg; 2007 Feb; 104(2):277-82. PubMed ID: 17242080
[TBL] [Abstract][Full Text] [Related]
13. QT and RR intervals in conscious and anesthetized guinea pigs with highly varying RR intervals and given QTc-lengthening test articles.
Hamlin RL; Kijtawornrat A; Keene BW; Hamlin DM
Toxicol Sci; 2003 Dec; 76(2):437-42. PubMed ID: 14600288
[TBL] [Abstract][Full Text] [Related]
14. Nonclinical proarrhythmia models: predicting Torsades de Pointes.
Lawrence CL; Pollard CE; Hammond TG; Valentin JP
J Pharmacol Toxicol Methods; 2005; 52(1):46-59. PubMed ID: 15975832
[TBL] [Abstract][Full Text] [Related]
15. QT prolongation in anaesthetized guinea-pigs: an experimental approach for preliminary screening of torsadogenicity of drugs and drug candidates.
Testai L; Calderone V; Salvadori A; Breschi MC; Nieri P; Martinotti E
J Appl Toxicol; 2004; 24(3):217-22. PubMed ID: 15211616
[TBL] [Abstract][Full Text] [Related]
16. Negative electro-mechanical windows are required for drug-induced Torsades de Pointes in the anesthetized guinea pig.
Guns PJ; Johnson DM; Weltens E; Lissens J
J Pharmacol Toxicol Methods; 2012 Sep; 66(2):125-34. PubMed ID: 22516473
[TBL] [Abstract][Full Text] [Related]
17. Gender differences in cardiac repolarization following intravenous sotalol administration.
Somberg JC; Preston RA; Ranade V; Cvetanovic I; Molnar J
J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):86-92. PubMed ID: 21527783
[TBL] [Abstract][Full Text] [Related]
18. In-vitro experimental models for the risk assessment of antibiotic-induced QT prolongation.
Lu HR; Vlaminckx E; Van de Water A; Rohrbacher J; Hermans A; Gallacher DJ
Eur J Pharmacol; 2006 Dec; 553(1-3):229-39. PubMed ID: 17054943
[TBL] [Abstract][Full Text] [Related]
19. HIV protease inhibitors induced prolongation of the QT Interval: electrophysiology and clinical implications.
Singh M; Arora R; Jawad E
Am J Ther; 2010; 17(6):e193-201. PubMed ID: 19636247
[TBL] [Abstract][Full Text] [Related]
20. Automated electrophysiology in the preclinical evaluation of drugs for potential QT prolongation.
Guo L; Guthrie H
J Pharmacol Toxicol Methods; 2005; 52(1):123-35. PubMed ID: 15936217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
